Keyword: Teva Pharmaceutical
Indian drugmakers pick up U.S. generics scripts; Chi-Med files for Hong Kong listing; an explosion at a Qilu Pharma subsidiary kills 10.
Traditional generics bigwigs Teva, Mylan, Sandoz, Amneal and Endo have lost out to a group of six competitors in terms of U.S. weekly prescriptions.
A judge questioned the Justice Department's motives for dismissing whistleblower allegations that UCB paid kickbacks to boost Cimzia scripts.
If you thought Teva went big-time with CEO Kåre Schultz's 2017 pay package, check out his 2018 numbers—especially his $20 million cash bonus.
Eighteen months after Apotex's founder was murdered, his family has hired a financial adviser to weigh its options, Bloomberg reports.
The FDA declared 40 generic hypertension drugs free from the three potentially carcinogenic compounds that cropped up in the "sartan" class.
Amgen wants to exit its collaboration with Novartis on migraine prevention drug Aimovig.
Teva, Sun, Lupin, Strides, WuXi STA and Cambrex all have developments.
Novo Nordisk is investing nearly $100 million in its massive site in Denmark to make next-generation insulins and other drugs.
Facing a long list of opioid mismarketing lawsuits, Purdue has agreed to its first settlement, numerous media outlets report.